Know Cancer

or
forgot password

Quantifying Micro RNA Levels to Obtain a Micro RNA Signature of Colon Tumor Phenotypes and Sub Phenotypes


N/A
18 Years
N/A
Not Enrolling
Both
Colorectal Carcinoma (CRC) Patients

Thank you

Trial Information

Quantifying Micro RNA Levels to Obtain a Micro RNA Signature of Colon Tumor Phenotypes and Sub Phenotypes


Inclusion Criteria:



Adult men and women over the age of 18 years who underwent colon resection of any kind are
suitable candidates for this study.

Exclusion Criteria:

Pregnant woman and children (under the age of 18 years) will not be included in this
study.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

identifying specific, relevant miRNAs that may serve as biomarkers to stratify CRC patients according to their clinical characteristics

Outcome Time Frame:

3 years

Safety Issue:

No

Principal Investigator

Shmuel Avital, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Meir Medical Center

Authority:

Israel: Clalit Health Services

Study ID:

0148

NCT ID:

NCT01712958

Start Date:

November 2012

Completion Date:

November 2015

Related Keywords:

  • Colorectal Carcinoma (CRC) Patients
  • CRC miRNA
  • Carcinoma
  • Colorectal Neoplasms

Name

Location